top of page

You never really know which patient will be THE ONE

 

As a gateway to abuse, the surgical setting is where many people are first exposed to opioids. And while surgeons recognize that abuse is a national crisis, many do not associate their prescribing of opioids as contributing to it. After all, they've been trained to control pain with opioids–it’s a habit for them. Every year, 70 million patients in the U.S. are prescribed opioids after surgical procedures and studies show that ONE in TEN will develop a dependence. So how can they know if their patient is the one at risk? They don’t. 

​

So Nukleus decided to take the challenge to the streets to highlight the issue as part of a prelaunch campaign to build awareness of a cultural health epidemic that could be helped by Pacira’s soon-to-be launched non-opioid pain reliever. We developed a powerful campaign focussed on provoking HCPs and patients to recognize that the post-surgical prescribing of opioids contributes to overuse and abuse, and that there are non-opioid alternatives to managing pain.

Pacira Biosciences

Opioid-dependence Awareness 

pills1.png
streetad
bus
subway


VIEW PROJECTS

​

 
 
Nukleus Healthcare Communications  |  Powerful human insight at the core of every brand story
 
New Business - General Inquiries | Carleen Niemiec, President/Creative Director  |  carleen@nukleushealth.com  |  609-374-4027 
​
Address | 40 Chesterfield-Georgetown Road, Chesterfield, New Jersey 08515 
​
©2020 Nukleus Communications LLC. All Rights Reserved.
​
​
bottom of page